Node Status
Learning Objectives
BPaLM regimen for DR-TB
Sub Nodes
- Evidence for the efficacy of BPaL regimen in DR-TB
- Rationale for continuation of Moxifloxacin in BPaLM regimen irrespective of FQ resistance
- Eligibility Criteria for BPaLM
- Relative contraindications Criteria for BPaLM
- Overview of Treatment Course for patients on BPaLM regimen
- Management of BPaLM ineligible patients
- Regimen modification for patients on BPaLM regimen
- Implementation Consideration for BPaLM regimen
- Extension criterion for BPaLM regimen
- Follow-up monitoring of BPaLM
- Screening of patients on BPaLM regimen for Linezolid toxicity
- Switching from BPaLM to another regimen